Why a Company Penalty Doesn’t End Director Liability in Australia

A $4 million corporate penalty and a separate personal legal action against the former CEO, both arising from the exact same set of facts. Most investors assume that once the company pays, the regulatory chapter closes. It does not.

Electro Optic Systems Holdings Limited (ASX: EOS) gave the market revenue guidance of at least $212.3 million between May and June 2022. By 25 July 2022, internal forecasts had dropped to approximately $164 million. The company did not correct the market until 31 October 2022, a gap of roughly 14 weeks. Declarations were made by the Federal Court that EOS had contravened s 674A(2) of the Corporations Act, with the Court ordering a $4 million pecuniary penalty as a consequence. On a separate track, ASIC brought its own proceedings against former CEO and Director Dr Ben Greene, targeting alleged directors’ duties violations connected to the same underlying events.

Here is how that dual accountability system works, and what it tells you about governance risk in the companies you hold. After this, you will understand that Australian corporate law runs two parallel enforcement tracks over the same governance failure, what personal duties directors owe, and what to look for in board conduct when assessing ASX-listed companies.

The EOS case in plain terms: two penalties from one failure

The sequence matters here, because it is the sequence that created the legal exposure.

1. May-June 2022: EOS communicated revenue guidance to the ASX of at least $212.3 million.
2. 25 July 2022: Internal forecasts fell to around $164 million, with the possibility of an additional $27 million on top of that figure.
3. 31 October 2022: EOS publicly corrected its guidance to the market, approximately 14 weeks after the internal downgrade.

That 14-week gap between internal awareness and public disclosure is the factual core of everything that followed. It is the gap that created exposure at both the corporate and individual level.

The disclosure obligation attaches at the point of internal awareness, not at the point of board sign-off or formal announcement preparation, a distinction at the heart of how continuous disclosure obligations are interpreted and enforced across ASX-listed companies.

The Federal Court, with Justice Ian Jackman presiding, issued formal declarations that EOS had breached s 674A(2) of the Corporations Act 2001 (Cth). The proceedings were resolved on the basis of facts and admissions that both parties had agreed upon. The Court imposed a $4 million pecuniary penalty on EOS, plus costs, calibrated to the company’s size and financial capacity.

ASIC’s media release on the EOS penalty confirms the agreed facts underlying both enforcement tracks, including the specific 14-week disclosure gap and the existence of separate proceedings against Dr Greene as an individual respondent.

ASIC Chair Joe Longo provided public commentary on the outcome, reinforcing the regulator’s position that timely disclosure of material information is a cornerstone of market integrity.

But the corporate penalty was not the end of the matter. ASIC initiated a separate action against Dr Ben Greene personally, alleging that his conduct during the relevant period amounted to breaches of directors’ duties. The corporate outcome settled the company’s liability. The individual proceedings address whether the person at the centre of the failure met his personal legal obligations. Those are two distinct questions under Australian law, and they are answered in two separate actions.

What duties directors actually owe under Australian law

You do not need a law degree to understand what directors owe. There are four core statutory duties under the Corporations Act 2001 (Cth), and each one is a distinct obligation you can name and recognise.

The detail that changes how you should think about these duties is their non-delegable character. A director cannot discharge their legal obligation by delegating disclosure oversight to management and assuming it is handled. Relying on a company’s disclosure framework or taking management representations on trust does not protect a director from personal liability if something goes wrong.

The Star Entertainment proceedings extended section 180 liability beyond financial compliance failures, confirming that executives who control the flow of risk information to the board can be held personally responsible even when the board itself is cleared, a principle that applies with equal force to disclosure decisions.

Three characteristics make these duties personally enforceable:

• They attach to the individual, not to the role or the company
• They persist after a director departs the company
• They cannot be contractually reassigned or waived

When you are evaluating governance quality in an ASX-listed company, knowing these duties exist and are personal gives you a framework for assessing whether a board is actively engaged or passively compliant. That distinction matters most when bad news is emerging inside the company.

What personal liability actually looks like: consequences for individual directors

Knowing that duties exist is one thing. Understanding what happens when they are breached is what makes the stakes real.

A director found to have breached their duties can face four categories of consequence:

• Civil pecuniary penalties, often in the seven-figure range per contravention under the current regime
• Disqualification from managing corporations for a set period or indefinitely
• Compensation orders requiring the director to reimburse the company or investors for losses
• Criminal prosecution, with potential imprisonment, where dishonesty or intentional misconduct is involved

These are not theoretical possibilities. They are the tools ASIC uses in enforcement proceedings, and the EOS matter illustrates how they apply in practice. The proceedings against Dr Greene carry the potential for personal financial penalties and professional consequences that are entirely separate from the $4 million penalty the company has already absorbed.

Why leaving the company does not close the regulatory chapter

This is the counterintuitive point that catches many investors off guard. Liability attaches to conduct during tenure, not to current employment status. Dr Greene’s departure from EOS did not extinguish his exposure. The proceedings against him are separate from and persist independently of the corporate penalty already applied to the company.

Australian enforcement timelines mean investigations or proceedings can continue for years after a director leaves. A “management clean-up” following a governance failure is a beginning of accountability, not the end of it. If you are assessing a company that has recently replaced senior leadership after a disclosure issue, any ongoing regulatory proceedings should remain part of your risk assessment. An executive resignation is not a governance reset; it is a personnel change.

How the two enforcement tracks run in parallel

Australian corporate enforcement is designed with two deliberately separate channels, and the EOS case is the worked example of both operating simultaneously.

The logic behind pursuing individuals as well as companies is straightforward. Company penalties are ultimately borne by shareholders. A $4 million fine comes out of the company’s cash, which means the people who already suffered from the disclosure failure (shareholders who traded on incomplete information) bear the cost again. Individual proceedings place consequences directly on the decision-makers, strengthening deterrence where it is most effective.

ASIC’s stated enforcement rationale centres on market integrity and investor protection. When specific individuals are central to a failure, separate actions target responsibility precisely rather than distributing it across the corporate entity. This is proportionate accountability by design, not an accidental doubling of punishment.

What this means for you in practice: a company settlement, however large, is not a reliable signal that individual accountability has been resolved. If you are following an enforcement case, treat the corporate and personal proceedings as independently live until both are concluded. One resolving does not predict or accelerate the other.

What investors should look for when assessing governance risk on the ASX

The legal mechanics matter, but they translate into three specific signals you can monitor from publicly available information. You do not need insider knowledge to apply this framework; you need to know what to look for in the materials that are already available.

1. Disclosure delays: Long gaps between internal recognition of a material change and disclosure to the market. The EOS case involved approximately 14 weeks between an internal revenue downgrade and public correction. Patterns of guidance followed by sharp, late revisions are the clearest observable warning sign.
2. Management transitions paired with regulatory scrutiny: Executive departures following governance issues should be read alongside any ongoing investigations or enforcement proceedings. A board shake-up is not a reset if ASIC is still pursuing the individuals involved.
3. Optimistic-then-revised guidance patterns: Companies that repeatedly issue guidance at the upper end of expectations and then revise downward warrant closer examination of board oversight and disclosure culture. One revision may be a forecasting miss; a pattern suggests a structural governance problem.

The 14-week gap in the EOS case is a concrete benchmark for what “material delay” looks like in a real enforcement context. When you see a company revise guidance months after the internal numbers changed, the EOS precedent tells you exactly how regulators view that behaviour.

Governance risk is about people, not just policies. Board charters and risk frameworks only work if individual directors actively engage with their duties. Your assessment should focus on track records, how boards respond to bad news, and whether disclosure patterns suggest active oversight or passive reliance on management. The fact that a passive or hands-off stance can itself constitute a breach of the duty of care and diligence under s 180 tells you where the legal line sits.

A structured governance risk assessment for ASX holdings goes beyond reviewing board charters; it requires examining how risk information travels from operational teams to senior executives, whether escalation failures are disclosed, and whether recent regulatory history suggests a pattern rather than an isolated event.

What the EOS proceedings confirm about accountability in Australian markets

The $4 million penalty against EOS and the separate proceedings against Dr Ben Greene together confirm a structural feature of Australian markets that every investor should understand: enforcement operates at both the corporate and personal level over the same governance failure. These are not redundant actions. They are two different questions, directed at two different entities, with two different sets of consequences.

For you as an investor, understanding director liability in Australia is not a niche legal concern. It is part of how you assess governance risk in ASX-listed companies. The existence of personal liability for directors is one of the mechanisms that creates an incentive for boards to disclose promptly and accurately. When that mechanism works, it directly affects the reliability of what listed companies tell the market.

Systemic governance failures at the operator level, where risk management is not integrated into daily operations and culture reinforces passive oversight rather than active challenge, represent the environment in which individual directors are most exposed to personal liability when a specific disclosure event occurs.

Continuous disclosure exists to keep all investors equally informed. Individual director accountability is part of the system that makes that obligation credible. The EOS matter confirms that the system has teeth at both levels, and that you should assess governance accordingly.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. These statements regarding ongoing proceedings are based on publicly available information and are subject to change based on future court outcomes and regulatory developments.